image credit- shutterstock
AusBiotech, Australia’s leading national industry body representing more than 3,000 life sciences members, has signed a partnership agreement with ANDHealth, the country’s premier provider of commercialisation support and services for the rapidly expanding digital and connected health sector.
This milestone agreement aims to enhance collaboration on mutual interests and support ongoing industry innovation.
Rebekah Cassidy, CEO of AusBiotech, commented, “This agreement between AusBiotech and ANDHealth represents a significant step forward in our commitment to supporting digital innovation, technology development and commercialisation within the life sciences sector. By collaborating, we can unlock new opportunities for innovation and support Australian biotech and medtech companies seeking to thrive on the global stage.
"The rapid pace of digital and technological advancements demands that our homegrown life sciences companies stay at the forefront of the digital revolution. This partnership with ANDHealth signals our commitment to prioritising knowledge-sharing for the benefit of our members and the entire sector,”
Bronwyn Le Grice, CEO and Managing Director ANDHealth, said, “Digital and connected health is the fastest growing field in health and life science technology, outpacing the more mature medical devices and pharmaceutical sectors. It makes this a timely opportunity for ANDHealth and AusBiotech to work closer together to maximise the health and economic benefits from this emerging sector possible for all Australians.
“The future of healthcare is digital and that is spreading across all streams of health and life sciences. This partnership will show the benefits of collaboration across different sectors to continue to position Australia as a leading research, innovation and commercialisation player on the global health and medical technology stage.”
